PEGASYS S.C. Injection 90μg (Peginterferon alfa-2a Vials) 90mcg

PEGASYS S.C. Injection 90μg contains peginterferon alfa-2a, a subcutaneous therapy used in certain medical conditions. This formulation supports immune response modulation in approved indications. Suitable for patients requiring interferon-based treatment. Always consult a healthcare provider for personalized guidance.

Strength

90mcg

Manufacturer / TM Owner

Chugai Pharmaceutical Co., Ltd.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

PEGASYS S.C. Injection 90μg is used to support treatment of chronic hepatitis B and C infections. It may also be prescribed for certain cancers when directed by a physician. The medication works by influencing the body’s immune response to viral activity. Patients often ask what is peginterferon alfa-2a used for, and it is primarily indicated for viral hepatitis management.

Side Effects

PEGASYS S.C. Injection 90μg may cause flu-like symptoms such as fever, fatigue, or muscle aches after administration. Some users report mild injection site reactions like redness or swelling. These effects are typically temporary and vary by individual. Most people tolerate the medication well over time with proper monitoring.

Precautions & Warnings

Store PEGASYS S.C. Injection 90μg as directed, usually refrigerated between 2°C and 8°C. Protect from light and avoid freezing. Do not use if the solution is discolored or contains particles. Always follow your healthcare provider’s instructions for safe handling and disposal of used supplies.

Avoid Interactions

PEGASYS S.C. Injection 90μg may interact with medications that affect the immune system, such as corticosteroids or certain chemotherapy drugs. Alcohol and other substances may influence how your body responds to treatment. Discuss all current medications and supplements with your doctor before starting this therapy.

Frequently Asked Questions

Peginterferon alfa-2a is primarily used to treat chronic hepatitis B and C infections as part of a prescribed regimen.

This medication is given as a subcutaneous injection, typically under medical supervision or as instructed by a healthcare provider.

Peginterferon alfa-2a is available by prescription only; consult a licensed provider for proper evaluation and access.

Common effects include flu-like symptoms, fatigue, and mild injection site reactions, which are usually temporary.

Pregnancy use should be discussed with a healthcare professional, as risks and benefits vary by individual circumstances.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.